Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.[1]

Mechanism of action

Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.[1]

References

  1. ^ a b "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.